Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|April 21, 2006
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumoursMaria Debiec-Rychter, Raf Sciot, Axel Le Cesne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumorsSimon Pacey, Richard H Wilson, Mike Walton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumorsKim Appleton, Helen J Mackay, Ian Judson, et al.
Journal of Proteomics|April 25, 2021
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometryMartina Milighetti, Lukas Krasny, Alex T J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2012
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancerPaul Nathan, Martin Zweifel, Anwar R Padhani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumorsRuth Plummer, Laura Vidal, Melanie Griffin, et al.
Cancer Research|June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomasIsabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trialMarie-Cécile Le Deley, Michael Paulussen, Ian Lewis, et al.
The Journal of Clinical Investigation|March 15, 2016
Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progressionTrevelyan R Menheniott, Louise O'Connor, Yok Teng Chionh, et al.
Pageof 16